References
- Lentaigne C, Greene D, Sivapalaratnam S, Favier R, Seyres D, Thys C, Grassi L, Mangles S, Sibson K, Stubbs M, et al. Germline mutations in the transcription factor IKZF5 cause thrombocytopenia. Blood 2019;134(23):2071–2081. 10.1182/blood.2019000782.
- Megy K, Downes K, Simeoni I, Bury L, Morales J, Mapeta R, Bellissimo DB, Bray PF, Goodeve AC, Gresele P, et al. Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: communication from the SSC of the ISTH. J Thromb Haemost 2019;17(8):1253–1260. 10.1111/jth.14479.
- Vannucchi AM. Pegasus causes inherited thrombocytopenia. Blood 2019;134(23):2000–2002. 10.1182/blood.2019002181.
- Goldman FD, Gurel Z, Al-Zubeidi D, Fried AJ, Icardi M, Song C, Dovat S. Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the ikaros gene. Pediatr Blood Cancer 2012;58(4):591–597. 10.1002/pbc.23160.
- Kuehn HS, Boisson B, Cunningham-Rundles C, Reichenbach J, Stray-Pedersen A, Gelfand EW, Maffucci P, Pierce KR, Abbott JK, Voelkerding KV, et al. Loss of B cells in patients with heterozygous mutations in IKAROS. N Engl J Med 2016;374(11):1032–1043. 10.1056/NEJMoa1512234.
- Churchman ML, Mullighan CG. Ikaros: exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia. Exp Hematol 2017;Febr(46):1–8.
- Churchman ML, Qian M, Te Kronnie G, Zhang R, Yang W, Zhang H, Lana T, Tedrick P, Baskin R, Verbist K. Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemia. Cancer Cell 2018;33(5):937–948.
- Leinøe E, Zetterberg E, Kinalis S, Østrup O, Kampmann P, Norström E, Andersson N, Klintman J, Qvortrup K, Nielsen FC, et al. Application of whole-exome sequencing to direct the specific functional testing and diagnosis of rare inherited bleeding disorders in patients from the öresund region, scandinavia. Br J Haematol 2017;179(2):308–322. 10.1111/bjh.14863.
- Gresele P, Orsini S, Noris P, Falcinelli E, Alessi MC, Bury L, Borhany M, Santoro C, Glembotsky AC, Cid AR, et al. Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the platelet physiology SSC. J Thromb Haemost 2020;18(3):732–739. 10.1111/jth.14683.
- Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College Of Medical Genetics And Genomics And The Association For Molecular Pathology. Genet Med 2015;17(5):405–424. 10.1038/gim.2015.30.
- Leinøe E, Gabrielaite M, Østrup O, Funding E, Greinacher A, Ostrowski SR, Zetterberg E, Rossing M. Outcome of an enhanced diagnostic pipeline for patients suspected of inherited thrombocytopenia. Br J Haematol 2019;186(2):373–376. 10.1111/bjh.15886.
- Greinacher A, Pecci A, Kunishima S, Althaus K, Nurden P, Balduini CL, Bakchoul T Diagnosis of inherited platelet disorders on a blood smear: a tool to facilitate worldwide diagnosis of platelet disorders. J Thromb Haemost 2017;15(7):1511–1521. 10.1111/jth.13729.
- Karczewski KJ, Francioli LC, Tiao G. Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. bioRxiv 2019;531210.
- Chen D, Uhl CB, Bryant SC, Krumwiede M, Barness RL, Olson MC, Gossman SC, Erdogan Damgard S, Gamb SI, Cummins LA, et al. Diagnostic laboratory standardization and validation of platelet transmission electron microscopy. Platelets 2018;29(6):574–582. 10.1080/09537104.2018.1476682.
- Grossfeld PD, Mattina T, Lai Z, et al. The 11q terminal deletion disorder: A prospective study of 110 cases. Am J Med Genet 2004;129A(1):51–61.
- Izumi K, Brooks SS, Feret HA, Zackai EH. 1.9Mb microdeletion of 21q22.11 within braddock-carey contiguous gene deletion syndrome region: dissecting the phenotype. Am J Med Genet Part A 2012;158(A(7)):1535–1541. 10.1002/ajmg.a.35368.
- Takenouchi T, Kosaki R, Niizuma T, Hata K, Kosaki K. Macrothrombocytopenia and developmental delay with a de novo CDC42 mutation: yet another locus for thrombocytopenia and developmental delay. Am J Med Genet Part A 2015;167(11):2822–2825. 10.1002/ajmg.a.37275.